Gloucestershire Royal Hospital is an acute District General Hospital on the Great Western Road in Gloucester operated by the Gloucestershire Hospitals NHS Foundation Trust.

There are 683 beds in Gloucester Royal Hospital.

During the past decade, Gloucester Royal Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gloucester Royal Hospital" #1 sponsor was "Medical Research Council" with 2 trials, followed by "Cardiff and Vale University Health Board" with 1 trials sponsored, "Leukemia Research Fund" with 1 trials sponsored, "Renovo" with 1 trials sponsored and "University College, London" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gloucester Royal Hospital" #1 collaborator was "Cancer Research UK" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Medical Research Council" with 1 trials as a collaborator and "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Gloucester Royal Hospital" are "Bladder Cancer" (1 trials), "Cervical Cancer" (1 trials), "Cicatrix" (1 trials), "Leukemia" (1 trials) and "Testicular Germ Cell Tumor" (1 trials). Many other conditions were trialed in "Gloucester Royal Hospital" in a lesser frequency.

Most popular intervention types in "Gloucester Royal Hospital" are "Drug" (6 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Avotermin" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Paclitaxel" (1 trials) and "Radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gloucester Royal Hospital" are 4 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gloucester Royal Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Gloucester Royal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gloucester Royal Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".